CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $873 | -63.7% | 32,057 | -70.4% | 0.01% | -60.9% |
| Q2 2023 | $2,408 | +960.8% | 108,242 | +930.8% | 0.02% | +666.7% |
| Q1 2023 | $227 | -91.3% | 10,501 | -91.9% | 0.00% | -91.9% |
| Q4 2022 | $2,620 | -98.9% | 129,010 | +1231.2% | 0.04% | +1133.3% |
| Q3 2022 | $248,000 | -82.8% | 9,691 | -84.0% | 0.00% | -81.2% |
| Q2 2022 | $1,440,000 | -38.2% | 60,574 | -41.5% | 0.02% | -5.9% |
| Q1 2022 | $2,331,000 | -19.4% | 103,508 | -29.2% | 0.02% | 0.0% |
| Q4 2021 | $2,892,000 | +164.1% | 146,103 | +162.6% | 0.02% | +142.9% |
| Q3 2021 | $1,095,000 | +81.9% | 55,642 | +103.3% | 0.01% | +16.7% |
| Q2 2021 | $602,000 | +150.8% | 27,374 | +170.4% | 0.01% | +200.0% |
| Q1 2021 | $240,000 | -21.6% | 10,123 | -53.2% | 0.00% | -85.7% |
| Q3 2019 | $306,000 | – | 21,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |